Literature DB >> 33765904

Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.

J Piątek1, M Bernatek1, H Krauss1, M Wojciechowska2, Z Chęcińska-Maciejewska3, P Kaczmarek1, H Sommermeyer1.   

Abstract

The aim of the study was to determine effects of administration of simethicone and a multi-strain synbiotic on the crying behaviour of colicky babies. The study design consisted of an open-label, two parallel treatment group study involving 87 infants aged 3-6 weeks with infantile colic (defined as crying episodes lasting 3 or more hours per day and occurring at least 3 days per week within 3 weeks prior to enrolment) randomly, unequally [1:1.5] assigned to receive simethicone (n=33) or a multi-strain synbiotic (n=54) orally for 4 weeks. The multi-strain synbiotic contained Lactobacillus acidophilus LA-14, Lacticaseibacillus casei R0215, Lacticaseibacillus paracasei Lp-115, Lacticaseibacillus rhamnosus GG, Ligilactobacillus salivarius Ls-33, Bifidobacterium lactis Bl-04, Bifidobacterium bifidum R0071, Bifidobacterium longum R0175 and fructooligosaccharides). Primary outcome measures were the responder rates (effect ≥50% reduction from baseline) of the measures 'crying days last 3 weeks', 'average evening crying duration last 3 weeks' and 'reduction of average number of crying phases per day last three weeks' at the end of treatment. The study is registered at ClinicalTrials.gov under NCT04487834. Significantly higher responder rates (effect ≥50% reduction from baseline) of the multi-strain synbiotic compared to simethicone were found for the measures 'crying days last 3 weeks' (72% vs 18%, P<0.0001) and 'average evening crying duration last 3 weeks' (85% vs 39%, P=0.0001). No significant difference was found for the measure 'reduction of average number of crying phases per day last three weeks' (50% vs 42%, P=0.4852). No adverse effects were reported for the two treatment groups. Based on these results, the multi-strain synbiotic can be considered as an interesting therapeutic possibility for the treatment of infantile colic, worthwhile to be investigated further in non-clinical and clinical studies.

Entities:  

Keywords:  extensive crying; gut microbiota; infantile colic; probiotic

Year:  2021        PMID: 33765904     DOI: 10.3920/BM2020.0160

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  3 in total

1.  Nine-Strain Bacterial Synbiotic Improves Crying and Lowers Fecal Calprotectin in Colicky Babies-An Open-Label Randomized Study.

Authors:  Malgorzata Bernatek; Jacek Piątek; Marcin Pszczola; Hanna Krauss; Janina Antczak; Paweł Maciukajć; Henning Sommermeyer
Journal:  Microorganisms       Date:  2022-02-12

Review 2.  The Future of Synbiotics: Rational Formulation and Design.

Authors:  David F Gomez Quintero; Car Reen Kok; Robert Hutkins
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

3.  Efficacy and Safety of a Colic Relief Remedy in Infantile Colic.

Authors:  Charles Evans; Wladimir P Lorentz
Journal:  Glob Pediatr Health       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.